Bolt co-founder Ryan Breslow launches Love.com, a marketplace with 600+ health supplements that raised $15M+; Breslow famously attacked Stripe's founders
Context & Ripple Effects
Ryan Breslow has been iterating fast since leaving Bolt: he stepped down as CEO in January 2022 after his tweets bashing YC and Stripe went viral, kept a 25% stake worth roughly $2.75B, and by September had launched Love as a DAO funding clinical trials in alternative medicine with $7.5M.
Love.com turns that experiment into a consumer business — a marketplace selling 600+ health supplements on more than $15M raised — while Bolt itself spent the same period consumed by lawsuits over its $355M Series E and a showdown with backer Activant.
First-order effects
- Love pivots from funding research to selling product directly: Breslow's $15M-plus now backs a 600-SKU supplement storefront instead of trial grants, putting him in competition with incumbent supplement e-commerce retailers immediately.
- Breslow's public persona — including his famous attacks on Stripe's founders — functions as the new company's distribution engine, converting notoriety into customer acquisition spend he doesn't have to pay for.
Second-order effects
- By pairing a supplement marketplace with a vehicle that funds clinical trials in alternative medicine, Love can market products as evidence-backed in a category where most rivals compete on price and branding alone — pressuring incumbents to invest in their own validation.
- Every launch keeps attention on Breslow personally rather than Bolt, which is still untangling its Series E fallout — reinforcing a split between the founder's new ventures and the troubled company he left behind.
Third-order effects
- If the sequence holds — fintech exit wealth funding alt-medicine research, then a consumer marketplace monetizing it — the structural play is vertical integration of wellness commerce where the retailer also controls the 'science' layer, raising questions regulators may eventually weigh.
- It also extends the pattern of high-profile founders serially launching ventures on the strength of prior equity and provocation-driven publicity, decoupling startup momentum from any single company's performance.
The trend: Founder-brand entrepreneurship is moving capital and audiences across sectors at speed — here from checkout payments through alt-medicine funding into consumer supplements — with each venture financed by the last one's equity and headlines.